Trexquant Investment LP Evolus, Inc. Transaction History

Trexquant Investment LP

$8.06 Billion
Q4 2024

A detailed history of Trexquant Investment LP transactions in Evolus, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 163,937 shares of EOLS stock, worth $2.29 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

163,937

Previous 247,560 33.78%

Holding current value

$2.29 Million

Previous $4.01 Million 54.89%

% of portfolio

0.02%

Previous 0.05%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$10.84 - $17.45 $906,473 - $1.46 Million	-83,623 Reduced 33.78%	163,937 $1.81 Million
Q3 2024 Nov 12, 2024	BUY	$10.66 - $17.48 $1.12 Million - $1.84 Million	105,157 Added 73.84%	247,560 $4.01 Million
Q2 2024 Aug 13, 2024	SELL	$10.45 - $13.76 $1.06 Million - $1.4 Million	-101,626 Reduced 41.65%	142,403 $1.55 Million
Q1 2024 May 14, 2024	BUY	$9.99 - $14.91 $858,680 - $1.28 Million	85,954 Added 54.38%	244,029 $3.42 Million
Q4 2023 Feb 09, 2024	BUY	$7.6 - $10.53 $514,352 - $712,649	67,678 Added 74.87%	158,075 $1.66 Million
Q3 2023 Nov 13, 2023	SELL	$7.15 - $10.2 $66,630 - $95,053	-9,319 Reduced 9.35%	90,397 $826,000
Q2 2023 Aug 11, 2023	SELL	$7.23 - $10.52 $97,272 - $141,536	-13,454 Reduced 11.89%	99,716 $724,000
Q1 2023 May 15, 2023	BUY	$7.81 - $11.05 $883,857 - $1.25 Million	113,170 New	113,170 $957,000
Q3 2022 Nov 14, 2022	BUY	$7.76 - $13.72 $280,167 - $495,346	36,104 New	36,104 $291,000
Q2 2022 Aug 11, 2022	SELL	$10.22 - $13.94 $137,847 - $188,022	-13,488 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$5.22 - $11.78 $93,218 - $210,367	-17,858 Reduced 56.97%	13,488 $151,000
Q4 2021 Feb 14, 2022	SELL	$5.37 - $8.38 $247,197 - $385,756	-46,033 Reduced 59.49%	31,346 $204,000
Q3 2021 Nov 12, 2021	BUY	$7.36 - $13.67 $569,509 - $1.06 Million	77,379 New	77,379 $590,000

Others Institutions Holding EOLS

# of Institutions

169

Shares Held

48.8M

Call Options Held

57.2K

Put Options Held

5.5K

View Full List

About Evolus, Inc.

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $785M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

More about EOLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account

Trexquant Investment LP Evolus, Inc. Transaction History